» Articles » PMID: 23879814

Optical Coherence Tomography for Presurgical Margin Assessment of Non-melanoma Skin Cancer - a Practical Approach

Overview
Journal Exp Dermatol
Specialty Dermatology
Date 2013 Jul 25
PMID 23879814
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

In the clinical setting, optical coherence tomography (OCT) is applicable for the non-invasive diagnosis of skin cancer and may in particular be used for margin definition prior to excision. In this regard, OCT may improve the success rate of removing tumor lesions more effectively, preventing repetitive excision, which may subsequently result in smaller excisions. In this study, we have aimed to evaluate the applicability of OCT for in vivo presurgical margin assessment of non-melanocytic skin tumors (NMSC) and to describe the feasibility of different scanning techniques. A total number of 18 patients planned for excision of lesions suspicious of NMSC were included in this study. Based on OCT, we defined the specific tumor margins on 19 lesions preoperatively using different scanning modalities. Sixty-one margin points and five complete tumor margins were analysed on 18 patients with a total of 19 lesions including 63% basal cell carcinoma (BCC) (n = 12), 16% (n = 3) squamous cell carcinoma (SCC) and 21% of other types of skin tumors (n = 4) were classified. In 84% of the cases (n = 16), the OCT-defined lateral margins correctly indicated complete removal of the tumor. The surgical margins chosen by the surgeon never fell below the OCT-defined margin. Regarding the techniques of marginal definition, punctual tumor border scan in the perpendicular direction, with an extension of free-run scans for unsure cases can hardly be recommended. This study shows that suspected NMSC can effectively be confirmed, and furthermore, resection margin can be minimized under OCT control without reducing the rate of complete removal.

Citing Articles

Novel imaging techniques for tumor margin detection in basal cell carcinoma: a systematic scoping review of FDA and EMA-approved imaging modalities.

Boostani M, Bozsanyi S, Suppa M, Cantisani C, Lorincz K, Banvolgyi A Int J Dermatol. 2024; 64(2):287-301.

PMID: 39358676 PMC: 11771686. DOI: 10.1111/ijd.17496.


Pixel-level classification of pigmented skin cancer lesions using multispectral autofluorescence lifetime dermoscopy imaging.

Vasanthakumari P, Romano R, Rosa R, Salvio A, Yakovlev V, Kurachi C Biomed Opt Express. 2024; 15(8):4557-4583.

PMID: 39346997 PMC: 11427192. DOI: 10.1364/BOE.523831.


Enhancing Melanoma Diagnosis with Advanced Deep Learning Models Focusing on Vision Transformer, Swin Transformer, and ConvNeXt.

Aksoy S, Demircioglu P, Bogrekci I Dermatopathology (Basel). 2024; 11(3):239-252.

PMID: 39189182 PMC: 11348198. DOI: 10.3390/dermatopathology11030026.


Combining Reflectance Confocal Microscopy, Optical Coherence Tomography and Ex-Vivo Fluorescence Confocal Microscopy for Margin Assessment in Basal Cell Carcinoma Excision.

Michelini S, Mandel V, Ardigo M, Ciardo S, Cota C, Cesinaro A Dermatol Pract Concept. 2024; 14(2).

PMID: 38810079 PMC: 11136106. DOI: 10.5826/dpc.1402a90.


Using optical coherence tomography to optimize Mohs micrographic surgery.

Akella S, Lee J, May J, Puyana C, Kravets S, Dimitropolous V Sci Rep. 2024; 14(1):8900.

PMID: 38632358 PMC: 11024158. DOI: 10.1038/s41598-024-53457-7.